6 matches for your search in the start-up spotlight
rss
Successfully birthed an extinct species
10-Apr-2025
Colossal Biosciences, the world’s only de-extinction company, announces the rebirth of the once extinct dire wolf, the world’s first successfully de-extincted animal. The dire wolf, largely assumed to be a legendary creature made famous from the HBO hit series Game of Thrones, was an American ...
Colossal Secures $200M in Series C Funding From TWG Global
21-Jan-2025
Colossal Biosciences, the world’s first de-extinction company, has announced $200M in a Series C financing by TWG Global, a diversified holding company with operating businesses and investments in technology/AI, financial services, private lending and sports and media, jointly led by Mark Walter ...
International team of scientists and start-up Colossal Biosciences decode the DNA of the bluebuck using state-of-the-art computer analysis software
17-Apr-2024
An international team of researchers led by the University of Potsdam has generated and analyzed the first high-coverage nuclear genome of the extinct blue antelope in cooperation with Colossal Biosciences and the Museum of Natural History Berlin. The genomic data shed light on the evolutionary ...
“This is a momentous step, with numerous applications”
11-Mar-2024
Colossal Biosciences, the world’s first de-extinction company, announces that their Woolly Mammoth team has achieved a global-first iPSC (induced pluripotent stem cells) breakthrough. This milestone advancement was one of the primary early goals of the mammoth project, and supports the ...
Colossal will assist the rescue mission by leveraging genome sequencing and gene editing methods to save the endangered species
22-Sep-2023
With only two living females left, the partnership will contribute to the genetic recovery of the northern white rhino from complete extinction. Colossal developed a pioneering toolkit for the challenging task to restore genetic diversity from museal specimens for a living population of ...
Colossal Biosciences Secures $150M Series B
02-Feb-2023
Colossal Biosciences, the world’s first de-extinction company, has announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund (USIT), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca ...
